BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim M, Kay CS, Jang WI, Kim MS, Lee DS, Jang HS. Prognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma: A multicenter analysis in Korea (KROG 14-17). Medicine (Baltimore) 2017;96:e7202. [PMID: 28614265 DOI: 10.1097/MD.0000000000007202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Valverde JM, Tohka J. Region-wise Loss for Biomedical Image Segmentation. Pattern Recognition 2022. [DOI: 10.1016/j.patcog.2022.109208] [Reference Citation Analysis]
2 Liang Z, Xue C, Chen Q, Li M, Li G, Feng H, Liu Y, Liu X, Ma S. Screening of Prognostic Biomarkers for Stereotactic Body Radiation Therapy in Primary Liver Cancer. Dose-Response 2022;20:155932582210975. [DOI: 10.1177/15593258221097589] [Reference Citation Analysis]
3 Sun J, Zhang A, Li W, Wang Q, Wang J, Fan Y, Sun Y, Li D, Zhang D, Duan X. CyberKnife Stereotactic Body Radiation Therapy as an Effective Treatment for Hepatocellular Carcinoma Patients With Decompensated Cirrhosis. Front Oncol 2020;10. [DOI: 10.3389/fonc.2020.00100] [Reference Citation Analysis]
4 Zhang L, Yan L, Niu H, Ma J, Yuan BY, Chen YH, Zhuang Y, Hu Y, Zeng ZC, Xiang ZL. A nomogram to predict prognosis of patients with unresected hepatocellular carcinoma undergoing radiotherapy: a population-based study. J Cancer 2019;10:4564-73. [PMID: 31528220 DOI: 10.7150/jca.30365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]